Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Tamsulosin highlighted at AUA meeting

June 7, 2001

Bayer's new PDE5 inhibitor improves ED over 12 weeks of therapy

June 6, 2001

ET antagonists may have therapeutic role in diabetic erectile dysfunction

June 6, 2001

Patent covers Ferring's new vasopressin V2 receptor agonists and uses

June 5, 2001

Palatin's PT-141 ED treatment well tolerated in phase I trial

June 5, 2001

AUA news: AII antagonist, ACE inhibitor protect against postischemic acute renal failure

June 5, 2001

Superior side effect profile of tolterodine vs. oxybutynin in overactive bladder

June 1, 2001

Potent new PDE5 inhibitors designed by Pfizer group

May 30, 2001

Takeda's Ixense approved in Europe for ED

May 30, 2001

Pfizer describes potent new phosphodiesterase inhibitors and potential therapeutic uses

May 29, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...